Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biocon’s drug Itolizumab gets approval to treat Covid-19

pharmaceutical-technologyJuly 14, 2020

Tag: Biocon , COVID-19 , Itolizumab

PharmaSources Customer Service